Results 271 to 280 of about 168,526 (308)
Unilateral Primary Aldosteronism Lacking KCNJ5 Somatic Mutations Is Associated With an Elevated Risk of New-Onset Diabetes. [PDF]
Chan CK+4 more
europepmc +1 more source
Clinical Significance of Skeletal Fat‐to‐Muscle Ratio in Idiopathic Hyperaldosteronism
ABSTRACT Objective The objective of this study is to evaluate the correlation between the fat‐to‐muscle ratio (FMR) and insulin resistance (IR) with aldosterone production among patients with idiopathic hyperaldosteronism (IHA). Methods Patients with primary aldosteronism were screened from those with secondary hypertension and then subtyped via ...
Yuhe Jiang+6 more
wiley +1 more source
Hypertension and hyperkalemia associated with Pro701Leu mutation in the NR3C2 gene: A case report. [PDF]
Kwon L+3 more
europepmc +1 more source
ABSTRACT Background Primary aldosteronism (PA) is a prevalent yet frequently underdiagnosed cause of secondary hypertension, affecting up to 10% of hypertensive individuals and contributing to increased cardiovascular risk. Accurate diagnosis is vital, as unilateral PA cases typically require surgical intervention, while bilateral disease is managed ...
Zin Htut+14 more
wiley +1 more source
Discordance between adrenal vein sampling and imaging: the role of unilateral cortisol excess. [PDF]
Grundy M+9 more
europepmc +1 more source
Stereospecificity in the Metabolism of Aldosterone in Man
Stanley Ulick
openalex +1 more source
ABSTRACT Introduction Intermittent fasting (IF) exposes patients with adrenal insufficiency (AI) to complications related to undertreatment. We aimed to determine the effect of IF during Ramadan on the quality of life of patients with secondary adrenal insufficiency (SAI) compared to healthy controls.
Mariam Mabrouk+6 more
wiley +1 more source
Meriones unguiculatus serves as a spontaneous primary aldosteronism rodent model. [PDF]
You M+14 more
europepmc +1 more source
Summary The effect of glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) on systolic blood pressure (SBP) in patients with obesity with or without diabetes remains unclear. The aim was to compare the effect of different drug–dose combinations of GLP‐1RAs on SBP.
Abraish Ali+5 more
wiley +1 more source